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• This study aimed to evaluate captopril-
induced sublethal effects in Cyprinus
carpio.
• Modifications were found in the activity
of SOD and CAT.
• Significant increases in HPC, LPX and
PCC occurred mainly in kidney, gill and
brain.
• Captopril induces oxidative stress on
C. carpio.
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To our knowledge, this is the first study to evaluate captopril-induced oxidative stress in fish, and specifically in
the common carp Cyprinus carpio. At present, very few studies in the international literature evaluate the suble-
thal effects of captopril on aquatic organisms such as fish, and available ones focus on determination of median
lethal concentration in crustaceans and algae. Also, studies evaluating these effects do not make reference to
the mechanism of action of this pharmaceutical or its toxicokinetics. This limits our knowledge of the character-
ization of the sublethal effects of this medication and of its potential ecological impact. The present study aimed
to evaluate the sublethal effects induced by three different concentrations of captopril, on C. carpio), by determi-
nation of activity of the antioxidant enzymes superoxide dismutase (SOD), catalase (CAT) and glutathione perox-
idase (GPx), as well as indicators of cellular oxidation: hydroperoxide content (HPC), lipid peroxidation (LPX)
and protein carbonyl content (PCC). Specimens were exposed for 12, 24, 48, 72 and 96 h to three different cap-
topril concentrations: 1 μg L−1, 1 mg L−1 and 100 mg L−1 (the first one has been detected environmentally, the
other two have been associated with diverse toxic effects in aquatic species), and brain, gill, liver, kidney and
blood samples were evaluated. Significant increases in HPC and LPX were observed mainly in kidney and gill,
while PCC also increased in brain. Modifications were found in the activity of SOD (mostly in kidney, brain and
blood), CAT (all organs) and GPx (kidney and gill). In conclusion, captopril induces oxidative stress in C. carpio.
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1. Introduction
The use of pharmaceuticals and personal care products (PPCPs) has
increased to an extremely high degree. These products are eliminated
from the body and enter sewage systems, eventually ending up in
wastewater treatment plant effluent as well as the aquatic environ-
ment. Since substances with pharmacological action have been de-
signed to carry out a biological function, depending on their
physicochemical properties (e.g. high liposolubility) they have a ten-
dency to bioaccumulate and can affect aquatic and terrestrial ecosys-
tems (Halling-Sørensen et al., 1998; Brandão et al., 2014). Data on the
ecotoxicity of pharmaceuticals and the effects induced by them on di-
verse aquatic species is scarce, and not all studies focus on the most
commonly prescribed and used types of medications.
Wastewater treatment plants and municipal, hospital and pharma-
ceutical industry discharges are themain sources of environmental con-
tamination by pharmaceuticals (Emmanuel et al., 2004; Joss et al., 2005;
Verlicchi et al., 2010). The wastewater treatment systems currently
used to reduce or eliminate the concentrations of these compounds
are not sufficiently effective (Kümmerer, 2001), so that these products
are now of environmental concern at world level and have been desig-
nated “emerging” contaminants (Fent et al., 2006; Richardson, 2009).
Captopril, 1-[(2S)-3-mercapto-2-methylpropionyl]-l-proline, is one
of these emerging contaminants, an angiotensin converting enzyme
(ACE) inhibitor that acts by blocking the protein peptidase from the ac-
tive center of the enzyme (Jackson, 2001). Captopril is used to treat ar-
terial hypertension, congestive heart failure and myocardial infarction,
and to preserve renal function in diabetic nephropathy (Armijo et al.,
2010; Tzanavaras, 2010).
According to theWorld Health Organization, cardiovascular diseases
(CVDs) are the main cause of death at world level (WHO, 2016). These
disorders accounted for 31% of all deaths worldwide in 2012 (17.5 mil-
lion people). Low- and middle-resource and income countries are the
ones most affected by CVDs. Of the 16 million annual deaths in individ-
uals under age 70, 82% occur in low- andmiddle-income these countries
and 37% are caused by CVDs (WHO, 2016). In Mexico, diabetes, CVDs
and heart disease remain the top causes of death, and together add up
to N50% of all deaths in the country. Information released by theNation-
al Council for the Prevention of Accidents (Consejo Nacional de
Prevención contra Accidentes, CONAPRA), which includes figures up
to 2011, reveals that the top causes of death in the country include dia-
betes (24.70%), heart disease (21.73%), CVDs (9.55%) and cirrhosis and
other liver diseases (8.68%).
Captopril has been detected in aquatic ecosystems at concentrations
of ng to μg L−1 (Chen et al., 2014). It has been shown to induce toxicity
in organisms such as daphnids, with a 48-h LC50 (median lethal concen-
tration) N 100 mg L−1; Desmodesmus subspicatus (24-h LC50 =
168 mg L−1); and Lemna minor (3 to 7-day LC50 = 25 mg L−1)
(Cleuvers, 2003, 2005; Nalecz-Jawecki and Sawicki, 2003;
Nalecz-Jawecki and Persoone, 2006; Park, 2005; Cunningham et al.,
2006; Kaza et al., 2007; NOAA, 2016).
Furthermore, captopril has been postulated as a free-radical scav-
enging agent due to the terminal sulfhydryl group in itsmolecular struc-
ture (Bagchi et al., 1989; Andreoli, 1993). In vitro studies indicate that
captopril acts as an antioxidant due to these two properties: being a
scavenger of reactive oxygen species (ROS) and capable of increasing
the levels of antioxidant enzymes such as superoxide dismutase (SOD)
and glutathione peroxidase (GPx) (Andreoli, 1993; De Cavanagh et al.,
1995). Thismedication has been shown to improve total antioxidant ca-
pacity in patients with hypertension (Schneider et al., 1990). A study by
Chopra et al. (1992) indicates that the –SH group present in captopril
structure is crucial in order for this pharmaceutical to be able to scav-
enge free radicals but not the proline portion.
In addition to its capacity to potentiate antioxidant activity in mam-
mals, captopril can undergo phase I biotransformation reactions, pro-
ducing ROS such as the superoxide anion (O2 • -) and hydrogen
peroxide (H2O2). These reactive species induce oxidative stress, which
is considered one of themainmechanisms of action of toxic substances.
Oxidative damage induced by ROS on lipids, proteins and DNA, and the
adverse effects of ROS on enzymatic antioxidantmechanisms in aerobic
organisms have been used in recent years as biomarkers for monitoring
of environmental pollution (Valavanidis et al., 2006). The major oxida-
tive stress biomarkers used in toxicological studies of aquatic systems
are lipid peroxidation (LPX), hydroperoxide content (HPC), protein ox-
idation, and enzymatic antioxidant activity (Droge, 2003).
Since no data are available regarding the concentrations of captopril
required to induce toxicity on fish species, methodologies need to be
established to determine the effects of this compound on species of eco-
logical and economic importance such as the common carp Cyprinus
carpio.
Bioindicators are used to evaluate the toxic impact of contaminants
in water bodies. Toxicity assays on fish are one of the most effective
methods for understanding the deleterious effects of environmental
contaminants in aquatic systems. Fish play a major role in aquatic
food webs, where they generally occupy an intermediate or higher po-
sition: they are not only fed upon by a variety of aquatic predators,
but are also a major source of food for humans at world level. The spe-
cies C. carpio is frequently used as a bioindicator, since cyprinids are
quantitatively the most important group of teleost fishes cultured
throughout the world for commercial purposes and are also very sensi-
tive and easy to maintain organisms.
Biomarkers are measurable internal indicators of changes in organ-
isms occurring at the molecular or cellular level, offering the possibility
of understanding environmentally mediated disease (Valavanidis and
Vlachogianni, 2010). Oxidative stress, one of the major mechanisms of
action of toxicants, is among the most frequently used biomarkers
since it is able to evaluate general damage induced on biomolecules
such as lipids, proteins and DNA (Barata et al., 2005). Oxidative damage
has been used in recent years as a biomarker for monitoring of environ-
mental pollution (Valavanidis et al., 2006).
The present study aimed to evaluate the sublethal effects induced by
captopril on brain, liver, kidney, gill and blood of C. carpio at three con-
centrations (1 μg L−1, 1mg L−1 and 100mg L−1), using oxidative stress
biomarkers.
2. Materials and methods
2.1. Test specimens
Cyprinus carpio specimenswere obtained from the carp culture facil-
ity in Tiacaque (State of Mexico) and transported to the Environmental
Toxicology Laboratory at the Faculty of Chemistry (UAEMex). The char-
acteristics of the organisms were: 21.3 ± 0.57 cm long and weighing
63.81± 5.7 g. These fishwere bred and cultured at the facility, ensuring
their being free of contaminants. During aquaculture, fish were not ex-
posed to any metals. Concentrations of As, Cd, Cu, Cr, Hg, Ni, Pb and Zn
were determined by atomic absorption spectrophotometry in water
from the aquaculture center. None of these metals were detected in
the water samples. Specimens used in assays were maintained in the
laboratory and placed in 160-L aquaria filled with dechlorinated water
and the necessary salts for maintenance of C. carpio for a 45-day accli-
mation period, and were fed Pedregal Silver™ fish food. The physico-
chemical characteristics of tap water reconstituted with salts during
acclimation were: temperature 21 ± 1 °C, oxygen concentration 75–
85%, pH 7.5–8.0, total alkalinity 18.1 ± 5.8 mg L−1, total hardness 18.7
± 0.6 mg L−1. A natural light/dark photoperiod was maintained.
2.2. Experimental design
Captopril, [N-[(S)-3-Mercapto-2-methylpropionyl]-L-proline, ≥98%
purity, was purchased from Sigma-Aldrich (St. Louis, MO)] in powder
form for use in the present study. A 100 mg L−1 solution of captopril
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in water was prepared, fromwhich dilutions were made to obtain the 1
μg L−1 and 1mg L−1 concentrations used in the sublethal toxicity assay.
Test systems (10-L fish tanks with five carp each) were set up for each
concentration (1 μg L−1, 1 mg L−1, 100 mg L−1) and exposure time
(12, 24, 48, 72 and 96 h) as well as one captopril-free system for each
exposure time (also with five carp) which was used as the control
group. The assay was performed in triplicate using a total of 300 fish.
Test systems were static without renewal, in accordance with OECD
(1992) guideline 203. At the end of each exposure time, specimens
were removed from the systems and placed in a fish tank containing
50 mg L−1 of clove oil (Yamanaka et al., 2011) to anesthetize them
prior to obtaining blood samples.
Bloodwas collected from the caudal vessel using a heparinized 1-mL
hypodermic syringe, and 200 μL phosphate buffered saline (PBS) pH 7.4
was added per each 50 μL blood. Fish were weighed and measured at
the end of the exposure period and no significant differences were
foundwith respect tomeasurements taken during the acclimation peri-
od (Section 2.1). Specimens were sacrificed euthanized and entire or-
gans (gill, liver, kidney and brain) were removed by dissection in an
ice bath (to obtain the gills a cut was made in the operculum, then the
fishwas cut laterally from pectoral fin to anal fin to extract the other or-
gans),weighed and homogenized in 1mL PBS pH 7.4, and centrifuged at
12,500 rpm and −4 °C for 15 min. The supernatant was used to deter-
mine oxidative stress biomarkers. Antioxidant activity was estimated
by determination of the activity of the enzymes SOD, catalase (CAT)
and GPx. The following indicators of cellular oxidation were deter-
mined: hydroperoxide content (HPC), lipid peroxidation (LPX) and pro-
tein carbonyl content (PCC).
2.3. Antioxidant activity evaluation
2.3.1. SOD activity evaluation (method of Misra and Fridovich, 1972)
To 80 μL of supernatant in a 1-cm cuvettewere added 520 μL carbon-
ate buffer solution [50 mM sodium carbonate (Sigma-Aldrich), 0.1 mM
EDTA (Vetec)] pH 10.2 plus 200 μL adrenaline (30 mM, Bayer). Absor-
bance was read at 480 nm, at 30 s and 5 min. SOD activity was deter-
mined by interpolating the data on a type curve. Results were
calculated as IU SOD mg protein−1.
2.3.2. CAT activity evaluation (method of Radi et al., 1991)
Supernatant (40 μL) was placed in a quartz cuvette and was added
2 mL isolation buffer solution [0.3 M sucrose (Vetec), 1 mM EDTA
(Vetec), 5 mM HEPES (Sigma-Aldrich) and 5 mM KH2PO4 (Vetec)]
plus 0.4 mL of an H2O2 solution (20 mM, Vetec). Absorbance was read
at 240 nm, at 0 and 60 s. The absorbance values obtained for these
times were substituted in the formula: CAT concentration = [(A0 −
A60) / MEC], where the MEC of H2O2 is 0.043 mM cm−1, and results
were expressed as μM H2O2 mg−1 protein.
2.3.3. GPx activity evaluation (method of Gunzler and Flohe-Clairborne,
1985 as modified by Stephensen et al., 2000)
To supernatant (100 μL) in a quartz cuvette was added 10 μL gluta-
thione reductase [2 U glutathione reductase (Sigma-Aldrich)] plus 290
μL reaction buffer [50 mM K2HPO4 (Vetec), 50 mM KH2PO4 (pH 7.0,
Vetec), 3.5 mM reduced glutathione (Sigma-Aldrich), 1 mM sodium
azide (Sigma-Aldrich), 0.12 mM NADPH (Sigma-Aldrich)] and 100 μL
H2O2 (0.8 mM, Vetec). Absorbance was read at 340 nm, at 0 and 60 s.
Fig. 1. Superoxide dismutase (SOD) activity in brain, liver, kidney, gill and blood of C. carpio exposed for 12, 24, 48, 72 and 96 h to captopril concentrations of 1 μg L−1 (C-1), 1mg L−1 (C-2)
and 100 mg L−1 (C-3). Values are the mean of three replicates ± SEM for each concentration and exposure time. N = 300. * Significantly different (p b 0.05) from the control group.
Lowercase letters indicate a significant difference relative to: aC-1, bC-2, cC-3, ANOVA and Tukey-Kramer.
813M.J.A. Cortes-Diaz et al. / Science of the Total Environment 605–606 (2017) 811–823
Results were obtained by using the equation: GPx concentration= [(A0
− A60) / MEC], where the MEC of NADPH is 6.2 mM cm−1, and were
expressed as mM NADPH mg−1 protein.
2.3.4. Total protein content determination (method of Bradford, 1976)
To 50 μL of supernatant was added 150 μL distilledwater and 2.5 mL
Bradford's reagent. This solution was shaken in the vortex and allowed
to rest for 5 min at ambient temperature while light protected. Absor-
bancewas read at 595 nm. The resultswere interpolated on a bovine al-
bumin curve. Total protein content was used to express the results of
the biomarkers used.
2.4. Indicators of cellular oxidation
2.4.1. HPC evaluation (method of Jiang et al., 1992)
To 50 μL of sample [previously deproteinized with 10% trichloroace-
tic acid (TCA, Sigma-Aldrich)] was added 450 μL of reaction mixture
[0.25 mM FeSO4, 25 mM H2SO4, 0.1 mM xylenol orange and 4 mM
butyl hydroxytoluene in 90% (v/v) methanol (all Sigma-Aldrich)]. The
mixture was incubated for 60 min at ambient temperature, and absor-
bance was determined at 560 nm against a blank containing only reac-
tion mixture. Results were interpolated on a type curve and expressed
as nM cumene hydroperoxide (CHP) mg−1 protein.
2.4.2. Thiobarbituric acid reactive substances assay (TBARS, method of
Büege and Aust, 1978)
To 100 μL of uncentrifuged sample was added Tris-HCl buffer solu-
tion (150mMpH7.4, Sigma-Aldrich) until a 1-mL volumewas attained.
This solution was incubated at 37 °C for 30 min, then supplemented
with 2 mL TCA-TBA reagent [0.375% thiobarbituric acid in 15% TCA
(both Sigma-Aldrich)]. The solution was heated for 15 min in a boiling
water bath, following which the sample was centrifuged at 3000 rpm
for 10 min, and absorbance was read at 535. Results were expressed
as mM malondialdehyde (MDA) mg−1 protein, using the MEC of 1.56
× 105 M−1 cm−1.
2.4.3. PCC evaluation (method of Levine et al., 1994 as modified by Parvez
and Raisuddin, 2005 and Burcham, 2007)
To supernatant (50 μL) was added 75 μL DNPH (10 mM, Sigma-
Aldrich) in HCl (2 M, Sigma-Aldrich). This was incubated at ambient
temperature for 1 h in the dark. Next, 250 μL of 20% TCA was added,
and the sample was allowed to rest for 15 min at 4 °C. The precipitate
was centrifuged at 16,000 rpm for 5 min. The bud was washed several
times with 1:1 ethanol/ethyl acetate (Sigma-Aldrich), then dissolved
in 1 mL guanidine solution (6 M, Sigma-Aldrich) pH 2.3, and incubated
at 37 °C for 30 min. Absorbance was read at 366 nm. Results were
expressed as μM reactive carbonyls (C = O) mg−1 protein, using the
MEC of 21,000 M cm−1.
2.5. Determination of captopril in water
2.5.1. Standards
The standard solution was a mixture of 550 mL methanol and
450 mL water which was added 0.05% of 85% phosphoric acid at
pH 2.85 ± 0.05 (37:63 v/v), and was then filtered and degassed. A cap-
topril standard solution (100 ppm)was prepared and stored at 4 °C. So-
lutions of 0.001, 0.1, 0.5, 1, 5, 10, 50, 75 and 100 ppm captopril were
prepared to calibrate the equipment.
Fig. 2. Catalase (CAT) activity in brain, liver, kidney, gill and blood of C. carpio exposed for 12, 24, 48, 72 and 96 h to captopril concentrations of 1 μg L−1 (C-1), 1 mg L−1 (C-2) and
100 mg L−1 (C-3). Values are the mean of three replicates ± SEM for each concentration and exposure time. N = 300. * Significantly different (p b 0.05) from the control group.
Lowercase letters indicate a significant difference relative to: aC-1, bC-2, cC-3, ANOVA and Tukey-Kramer.
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2.5.2. Equipment
Captopril was analyzed in a high-performance liquid chromatogra-
phy (HPLC) system (Thermo Finnigan Surveyor LC Pump) with auto-
mated injector, UV–Vis PDA detector and surveyor autosampler. The
stationary phase was analyzed in a Kromasil 5 μm C18 column (150
× 4.6 mm) at ambient temperature. The mobile phase was: 550 mL
methanol plus 450mLwater whichwas added 0.05% of 85% phosphoric
acid, pH adjusted to 2.85 ± 0.05 (37:63 v/v), and was then filtered and
degassed. Operating conditions were: flow rate 1 mL min−1, injection
volume 100 μL, wavelength 220 nm. Chromatography was performed
at ambient temperature. The detection limit was 0.01 μg mL−1 and
the quantification limit was 0.076 μg mL−1.
2.5.3. Calibration curves
The calibration curve for captopril was determined using standard
solutions (0.001, 0.1, 0.5, 1, 5, 10, 50, 75 and 100 ppm), with a 55:45
mixture of methanol/water and phosphoric acid at pH 2.85 ± 0.05 (R2
=0.9982). Analyzed sampleswere prepared by dilution of the stock so-
lution on the day of analysis. Themobile phasewas passed at regular in-
tervals to clean the detector.
2.5.4. Water samples from test systems
Water samples (2mL) were collected in glass vials directly from the
test systems at 12, 24, 48, 72 and 96 h, and refrigerated at 4 °C for sub-
sequent determination of captopril concentrations. Volumes of 100 μL
were injected in the HPLC system, which was operated as described
above. The procedure was performed in triplicate. When analyzed sam-
ples fell outside the range of the type curve, dilutions were performed.
Results were multiplied by the dilution factor and expressed as time-
weighted mean concentrations of captopril.
2.6. Animal welfare
This protocol was reviewed and approved by the Bioethics Commit-
tee of the Universidad Autónoma del Estado de México (UAEM) to en-
sure that it was carried out in accordance with institutional standards
for the care of animal subjects. Provisions in the official Mexican norm
on breeding, care and use of laboratory animals (NOM-062-ZOO-
1999) were also taken into account.
2.7. Statistical analysis
To evaluate sublethal toxicity assay results (oxidative stress bio-
markers), after replication of data normality and homogeneity of vari-
ance (verified by Shapiro-Wilk and Levene's tests), results were
examined by one-way analysis of variance (ANOVA) followed by a
Tukey-Kramer multiple comparisons test with a 95% confidence limit
to determine differences betweenmeans. Pearson's correlation analysis
was performed to determine potential correlations between captopril
concentrations at the different exposure times and oxidative stress bio-




SOD activity results are shown in Fig. 1. A significant increase com-
pared to the control group was observed with C-1 (1 μg L−1) at 12, 24
and 48 h in brain; at 72 and 96h in liver; at all exposure times in kidney;
at 12, 48, 72 and 96 h in gill; and from 24 h up to 96 h in blood.With C-2
Fig. 3.Glutathioneperoxidase (GPx) activity in brain, liver, kidney, gill and blood of C. carpio exposed for 12, 24, 48, 72 and96 h to captopril concentrations of 1 μg L−1 (C-1), 1mg L−1 (C-2)
and 100 mg L−1 (C-3). Values are the mean of three replicates ± SEM for each concentration and exposure time. N = 300. * Significantly different (p b 0.05) from the control group.
Lowercase letters indicate a significant difference relative to: aC-1, bC-2, cC-3, ANOVA and Tukey-Kramer.
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(1mg L−1), significant increases were found from 12 h to 72 h in brain;
at 12, 48, 72 and 96 h in liver; from 24 h to 96 h in kidney; at 72 and 96 h
in gill, and at 48 h in blood. With C-3 (100 mg L−1), increases with re-
spect to the control group occurred at 12, 24 and 72 h in brain; at 48
and 96 h in liver; from 48 h to 96 h in kidney; at 96 h in gill; and at
24, 72 and 96 h in blood.
3.1.2. CAT activity
Fig. 2 shows CAT activity results. Significant increases compared to
the control group were observed with C-1 (1 μg L−1) at 12, 48, 72 and
96 h in brain and kidney; from 24 h to 96 h in liver; at 12, 24, 48 and
96 h in gill; and from 12 h to 72 h in blood. With C-2 (1mg L−1), signif-
icant increases were found at 12, 24 and 96 h in brain; from 24 h to 96 h
in liver and blood; at 12, 24 and 72 h in kidney; and at 12, 24, 48 and
96 h in gill. With C-3 (100 mg L−1), significant increases occurred at
12, 72 and 96 h in brain; from 24 h to 96 h in liver and blood; from
24 h to 72 h in kidney; and at 24, 48 and 96 h in gill.
3.1.3. GPx activity
Results of GPx activity are shown in Fig. 3. Significant increases with
respect to the control group were seen with C-1 (1 μg L−1) at 96 h in
brain and blood; at all exposure times in liver and kidney; and at 12,
48, 72 and 96 h in gill. With C-2 (1 mg L−1), increases relative to the
control group were observed at 12, 72 and 96 h in brain; at 48, 72 and
96 h in liver; and at all exposure times in kidney and gill, while in
blood no modifications were found with respect to the control group.
With C-3 (100 mg L−1), increases were also seen at 24, 72 and 96 h in
brain; at 24 and 48 h in liver; and at all exposure times in kidney and
gill, while in blood a decrease was observed at 48 h.
3.2. Indicators of cellular oxidation
3.2.1. HPC
HPC results are shown in Fig. 4. Significant increases were seen in
comparison to the control group with C-1 (1 μg L−1) at 12 and 48 h in
brain; at 12, 72 and 96 h in liver; at 24, 48, 72 and 96 h in kidney and
blood; and at all exposure times in gill. With C-2 (1mg L−1), significant
increases were found at 12 and 72 h in brain; at 24, 48, 72 and 96 h in
liver and kidney; at all exposure times in gill; and at 72 and 96 h in
blood. With C-3 (100 mg L−1), significant increases occurred at 24, 72
and 96 h in brain and gill; from 24 h to 96 h in blood; and at all exposure
times in liver and kidney.
3.2.2. LPX
LPX values are shown in Fig. 5. Significant increases compared to the
control group were observed with C-1 (1 μg L−1) at 12, 24 and 48 h in
brain; at 48, 72 and 96 h in liver; at 12, 48, 72 and 96 h in kidney; and
at all exposure times in gill, while no significant differences (p N 0.05)
were found in blood. With C-2 (1 mg L−1), significant increases were
also observed at 12, 48, 72 and 96 h in brain; from 48 h to 96 h in
liver; at all exposure times in kidney; and from 12 h to 72 h in gill,
while no significant increases were found in blood. With C-3
(100 mg L−1), significant increases occurred at 24, 72 and 96 h in
Fig. 4.Hydroperoxide content (HPC) in brain, liver, kidney, gill and blood of C. carpio exposed for 12, 24, 48, 72 and 96 h to captopril concentrations of 1 μg L−1 (C-1), 1 mg L−1 (C-2) and
100 mg L−1 (C-3). Values are the mean of three replicates ± SEM for each concentration and exposure time. N= 300. CHP= cumene hydroperoxide. * Significantly different (p b 0.05)
from the control group. Lowercase letters indicate a significant difference relative to: aC-1, bC-2, cC-3, ANOVA and Tukey-Kramer.
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brain and gill; at 24, 48 and 96h in liver; at 12, 48, 72 and96h in kidney;
and at 96 h in blood.
3.2.3. PCC
PCC values are shown in Fig. 6. Significant increases with respect to
the control group were observed with C-1 (1 μg L−1) at 24, 48 and
96 h in brain; at 48, 72 and 96 h in liver and blood; and at all exposure
times in kidney and gill.With C-2 (1mg L−1), significant increaseswere
observed at 12, 24, 72 and 96 h in brain; at 24, 48 and 96 h in liver; at all
exposure times in kidney; from12 h to 72 h in gill; and at 72 and 96 h in
blood. With C-3 (100 mg L−1), significant increases occurred at 12, 72
and 96 h in brain; at 24 and 96 h in liver; at all exposure times in kidney
and gill; and at 72 and 96 h in blood.
3.2.4. Changes in oxidative stress biomarkers
Table 1 shows the percentage change in each oxidative stress bio-
marker in each organ at the different exposure times. Positive values in-
dicate increases in the specific biomarker and negative values decreases
with respect to the corresponding control group.
3.3. Captopril concentrations in test systems
Table 2 shows the captopril concentrations determined in water
from test systems at the different exposure times. Fully 56–62% of the
initial captopril concentration placed in the test systems had been lost
by 12h of exposure and this loss increased gradually thereafter reaching
86–89% by the end of the assay at 96 h.
3.4. Pearson's correlation analysis
Table 3 shows the correlations found between oxidative stress bio-
markers assayed in the different organs, and exposure times and capto-
pril concentration in water. Values in bold denote a greater degree of
correlation between the variables analyzed. Enzymatic activity shows
a greater degree of correlationwith C-1 and C-3, suggesting the absence
of concentration-dependent effects. Similarly, in indicators of cellular
oxidation, there is also a greater degree of correlation with C-1 and C-
3. As regards exposure times, enzymatic activitywasmore closely corre-
lated with 12 and 96 h, while indicators of cellular oxidation correlated
most with 12 h.
4. Discussion
Captopril, is an antihypertensive of high consumption worldwide,
can enter aquatic systems through hospital, industrial and municipal
wastewater discharge, eliciting sublethal effects on hydrobionts and
having an ecological impact. To our knowledge, the present study is
the first to evaluate captopril-induced oxidative stress in fish, and spe-
cifically in C. carpio. Currently, there are few studies in the international
literature on the occurrence and sublethal effects of thismedication, and
existing ones focus on determination of the LC50 in crustaceans and
algae. There are no studies on its mechanism of action or toxicokinetics.
This limits our knowledge of the characterization of the sublethal effects
of this pharmaceutical and its potential impact as an environmental pol-
lutant. Therefore, it is of fundamental importance to conduct studies
evaluating the effects of captopril on higher aquatic species such as fish-
es of commercial interest like C. carpio. The results of our study show
Fig. 5. Lipid peroxidation (LPX) in brain, liver, kidney, gill and blood of C. carpio exposed for 12, 24, 48, 72 and 96 h to captopril concentrations of 1 μg L−1 (C-1), 1 mg L−1 (C-2) and
100 mg L−1 (C-3). Values are the mean of three replicates ± SEM for each concentration and exposure time. N = 300. MDA = malondialdehyde. * Significantly different (p b 0.05)
from the control group. Lowercase letters indicate a significant difference relative to: aC-1, bC-2, cC-3, ANOVA and Tukey-Kramer.
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that captopril induces oxidative stress on the common carp, affecting
biomolecules such as lipids and proteins. This model may be useful in
other fish species and may help determine the ecological impact of
this compound in aquatic systems.
A large variety of pharmaceutical substances have been detected in
diverse environmental compartments, particularly water bodies
(Halling-Sørensen et al., 1998; Heberer, 2002; Heberer et al., 2002;
Nikolaou et al., 2007; Jiang et al., 2011).Within this group of substances
are some pharmaceutical products with cardiovascular action, and
prominent among the latter are beta-blockers, captopril is one of them
(Gros et al., 2007; Valcárcel et al., 2011). These products induce toxicity
on zooplankton (in crustaceans such asDaphniamagna) and benthic or-
ganisms (Fent et al., 2006). As has been stated, there are few studies re-
garding the sublethal effects of captopril and its environmental
occurrence, despite the fact that this pharmaceutical is extensively
used globally due to its great efficacy as well as the elevated incidence
of CVD.
Results of the present study are consistent with previous findings in
mammals (De Cavanagh et al., 1995) since captopril induced significant
increases in SOD, CAT and GPx activity. SOD activity increased in almost
all organs evaluated at all exposure times and concentrations; kidney,
liver and gill being the organs in which this effect was most evident. A
similar behaviorwas seenwith CAT andGPx activity,with important in-
creases in the activity of both enzymes occurring also in brain. Increased
SOD, CAT and GPx activity has also been observed in the presence of
emerging contaminants (Islas-Flores et al., 2013, 2014; SanJuan-Reyes
et al., 2013, 2015; Elizalde-Velázquez et al., 2016). Although the studies
cited usedmedications from other pharmaceutical classes, they all have
in common thatmost of the pharmaceuticals undergo cytochrome P450
(CYP)-mediated phase I biotransformation, in the process of which ROS
are produced that are responsible for induction of antioxidant enzymes
and increases in indicators of cellular oxidation. It should be noted that
the genome of C. carpio has been sequenced and CYP is known to be
present in the fish (Stegeman and Livingstone, 1998).
The enzymes evaluated in our study constitute the principal scav-
engingmechanisms of themain species of ROS produced by cellular ac-
tivity and are therefore the first line of defense against oxidative stress.
The enzyme SOD catalyzes the dismutation of superoxide anion (O2*) to
hydrogen peroxide (H2O2), which is converted to O2 and water by CAT
and GPx (Van der Oost et al., 2003). Although several in vitro studies
refer to captopril as a ROS scavenger (Egan et al., 1988), not all studies
support this idea (Kukreja et al., 1990).
Increased production of ROS implies not only an increase in the
levels of antioxidant enzymes, it can also induce cellular damage
through oxidation of important biomolecules such as lipids and pro-
teins, resulting in higher levels of LPX and oxidized proteins (Shacter,
2000; Gómez-Oliván et al., 2014).
The LPX process involves a series of chain reactions in which pro-
oxidant agents, such as free radicals or non-radical species with a high
oxidant capacity, attack lipids that have carbon-carbon double bonds,
in particular polyunsaturated fatty acids. This implies the removal of
one hydrogen atom from a CH3 group, with oxygen interstation,
resulting in peroxyl and hydroperoxide radicals. In turn, hydroperox-
ides readily break down to diverse chemical species such as lipid alkoxy
radicals, aldehydes (MDA), alkenes (4-hydroxynonenal), lipid epoxides
and alcohols,most ofwhich are toxic (Porter et al., 1995; Yin et al., 2011;
Ayala et al., 2014). Among the substrates of these products are DNA and
proteins that are especially sensitive to oxidation by these compounds.
Fig. 6. Protein carbonyl content (PCC) in brain, liver, kidney, gill and blood of C. carpio exposed for 12, 24, 48, 72 and 96 h to captopril concentrations of 1 μg L−1 (C-1), 1 mg L−1 (C-2) and
100mg L−1 (C-3). Values are themean of three replicates± SEM for each concentration and exposure time.N=300. * Significantly different (p b 0.05) from the control group. Lowercase
letters indicate a significant difference relative to: aC-1, bC-2, cC-3, ANOVA and Tukey-Kramer.
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Table 1
Percentage change in oxidative stress biomarkers, induced by exposure to captopril.
ORGAN ASSAY SOD CAT GPX HPX LPX PCC
Time (h) C-1 (%) C-2 (%) C-3 (%) C-1 (%) C-2 (%) C-3 (%) C-1 (%) C-2 (%) C-3 (%) C-1 (%) C-2 (%) C-3 (%) C-1 (%) C-2 (%) C-3 (%) C-1 (%) C-2 (%) C-3 (%)
Brain 12 105.3 27.8 −2.7 −109.7 −204.2 −1801.7 782.3 −813 29,981.9 −3787.7 −584.2 −67.6 −88.4 −97.7 −100.3 2.7 −103.1 52.5
24 77.4 3.2 1.1 −64 −182.7 −861.2 371.4 −680.3 −59,287.6 8614.7 2219.5 −357.7 −116.1 −101.3 −99.8 −1.5 −98.7 −72.4
48 34.3 4.9 4 −18.9 −155 −423 172.8 −1016 −25,737.1 2433.1 1307.7 −409.2 −131.3 −105.4 −99.6 −5.5 −95.8 −76.6
72 29 15.7 21.6 37.3 28.4 −60.6 −313.7 −941.7 −4459 373.5 −219.1 261.5 −219.4 −158.7 −96.4 −39.2 −82.1 −131.4
96 3.3 −14.1 −0.6 −95.5 −2963.6 −3187.1 7.5 −107.9 16,732.4 −15,607.3 −207,069 6397.1 −103.1 −99.3 −100.6 1.3 −101.2 −101.6
Liver 12 2.4 14.8 −0.5 −103.2 −4414.8 −36,890.3 735.6 −812.6 169,735.7 −20,987.7 −2953.1 −92 −96.9 −99.5 −100.1 0.5 −100.5 9.3
24 17.6 37.5 9.3 −75.3 −528.1 −2300.3 335.6 −545.6 −5992.9 998.3 197.5 −108.6 −155 −115.5 −98.1 −15.1 −90.3 −16.9
48 18 53.6 70.2 31 72.1 50.2 −30.3 −198 −381.9 92.9 −406.1 −908.4 123.7 33.2 −108.7 −427.2 −445.3 −51
72 31.3 103.6 50.6 −51.2 −263.3 −465.7 76.9 −250.2 −594.5 137.6 79 −117 −248.1 −280.3 −52.9 −81.1 −67.3 −42.5
96 6 127.5 6.8 −94.7 −1684.4 −1854.6 10.1 −110.7 −1734 1466.8 14,418.2 −877.4 −106.1 −107.2 −93.8 −12.5 −88.2 −89.9
Kidney 12 49.2 28.4 21.5 −24.2 −149.3 −1343.9 800.3 −3402.9 −15,905.5 367.4 −54.1 −96 77.4 −78.9 −99.5 26.1 −66.3 −30.9
24 26.8 15.4 15.7 1.9 −92.8 −486.7 424.4 21,969 139,727.8 536 26.3 −105.4 −500.8 −193.4 −100.1 −48.2 −90.4 −14.3
48 169.4 138.3 137.8 −0.3 −100.2 −308.7 208.1 −62,332.7 −45,333.1 −27.3 −113.1 −63.4 −44 61.2 −100.1 −263.5 499.2 −887.9
72 32.3 45.3 32.3 −28.8 −189.2 −362.8 91.7 −418.7 −1397.6 233.8 154.9 −142.7 −192.1 −182.2 −87 −52.3 −72.8 −49
96 26.9 55.2 22.6 −59 −319 −432.2 35.5 −160.2 −807.6 404 1037.4 −340 −132.8 −132.9 −83.5 −37.1 −72 −78.8
Gill 12 67.3 −5.3 15.6 −392.2 −682.8 −5789.6 748 −290.7 −1967.3 576.7 −22.9 −99.6 334.9 −41.9 −97.9 133.4 −60.2 −39.6
24 2.7 19.9 23.2 16.9 518.2 2059.3 297.4 1662.2 7064.3 325 9.3 −99.5 −1171.4 −460.4 −106.5 −76.9 −93.4 −6.1
48 50.4 22.7 −4.8 −121.2 −340.5 −809.4 137.7 −213.6 4333 −2128.8 −1645.9 103.4 −106.3 −95 −102.2 7.6 −107.1 −203.6
72 39.7 68.7 −8.4 −112.2 −382.6 −631.4 65 −158 1788.9 −1232.5 −1995.4 216 −110.8 −91 −105.1 15.5 −114 −152.8
96 45.3 52.2 25.6 −51 −212.5 −321.4 51.2 −200.5 −884 341 565.6 −276 −148.8 −143.6 −83.8 −41.7 −72 −73.9
Blood 12 −32 −4 −44 1000 −3225 −26,975 736.4 −26.4 −40.1 52.1 −92.9 −99.7 7.2 −86.1 114.7 −233.2 −3317.7 3229.1
24 58.5 4.9 24.4 400 583.3 2330.6 299.5 −25.1 −203 708.1 136.4 −94.1 −169 −123.9 −39 −68.5 −59.5 −36.9
48 13.5 37.8 10.8 −71.4 −628.6 −1409.5 124.2 −273.9 −2633.9 861.5 593.4 −142.1 −123.9 −114.4 −95.7 −16.4 −86.8 −38.9
72 100 26.5 38.2 44.4 −55.6 −177.2 218.9 392.5 926.5 136.1 −37.8 −78.6 107.8 −20.8 −102.2 392.6 264.1 −435.9
96 96.8 93.5 138.7 48.3 −50.1 −152.2 203.7 322 132.1 −59 −128.9 −15.3 −88.2 49.5 −62.5 −226.4 156.8 −1126.1











In particular, MDA and 4-hydroxynonenal can form adducts that play a
major role inmany cell processes andmay be involved in secondary del-
eterious reactions by promoting intra- or intermolecular protein-DNA
crosslinks that can induce profound alterations in the biochemical prop-
erties of biomolecules, facilitating the development of diverse patholog-
ical conditions (Ayala et al., 2014).
Our results show that captopril exposure induced overall increases
in LPX and HPC at all three concentrations in all organs evaluated. This
may be due to an increment in the release of free radicals formed during
captopril biotransformation in the fish by CYP activity.
In general, the biotransformation reactions of pharmaceuticals such
as captopril, inwhich isoenzymes such as CYPparticipate, producemore
polar and hydrosoluble inactive metabolites that are readily eliminated.
However, in some cases, themetabolites produced have higher levels of
biological activity and consequently toxic properties which can induce
oxidative stress.
Table 2
Captopril concentrations in water from the test systems at the different exposure times.
Initial
concentration




Captopril 1 μg L−1 12 0.3849 ± 0.0002 μg L−1 61.51
24 0.3512 ± 0.0001 μg L−1 64.88
48 0.3162 ± 0.0001 μg L−1 68.38
72 0.2236 ± 0.0001 μg L−1 77.64
96 0.1127 ± 0.0001 μg L−1 88.73
1 mg L−1 12 0.4351 ± 0.0001 mg L−1 56.49
24 0.3602 ± 0.0001 mg L−1 63.98
72 0.2186 ± 0.0001 mg L−1 78.14
96 0.1368 ± 0.0001 mg L−1 86.32
100 mg L−1 12 41.534 ± 0.01 mg L−1 58.47
24 34.046 ± 0.01 mg L−1 65.96
48 33.742 ± 0.01 mg L−1 66.26
72 20.844 ± 0.01 mg L−1 73.16
96 11.656 ± 0.01 mg L−1 88.35
Table 3
Pearson's correlation analysis between oxidative stress biomarkers, and captopril concentrations and exposure times.
Antioxidant activity Oxidative damage
Biomarkers Organs Time (h) Concentration of captopril in water Biomarkers Organs Time (h) Concentration of captopril in water
C-1 C-2 C-3 C-1 C-2 C-3
SOD BRAIN 12 −0.413 0.988 0.968 HPX BRAIN 12 0.865 0.959 −0.361
24 0.799 0.970 0.996 24 0.497 0.374 −0.803
48 0.876 0.932 0.900 48 −0.621 −0.367 −0.784
72 0.965 0.981 0.975 72 0.312 0.956 0.498
96 0.734 0.853 0.996 96 −0.681 −0.561 0.276
LIVER 12 0.987 0.851 0.919 LIVER 12 −1.000 −0.586 0.575
24 0.970 0.847 0.944 24 0.931 0.636 −0.407
48 0.836 0.789 0.900 48 −0.978 0.559 −0.009
72 0.709 0.760 0.945 72 0.140 0.751 −0.817
96 0.922 0.873 0.901 96 −0.133 0.218 0.213
KIDNEY 12 0.757 0.993 0.950 KIDNEY 12 0.897 0.218 0.618
24 0.908 0.988 0.973 24 0.870 −0.813 −0.487
48 0.888 0.949 0.899 48 0.987 −0.134 0.496
72 0.871 0.964 0.983 72 0.199 −0.146 0.484
96 0.964 0.798 0.812 96 0.911 0.873 −0.056
GILL 12 0.676 0.910 0.901 GILL 12 −0.765 −0.736 −0.921
24 0.783 0.501 0.844 24 −0.097 0.714 0.833
48 0.998 0.840 0.971 48 −0.545 −0.152 0.869
72 0.868 0.922 0.843 72 0.431 −0.006 −0.986
96 0.946 0.872 0.880 96 −0.926 −0.029 0.855
BLOOD 12 0.969 0.993 0.996 BLOOD 12 0.352 −0.182 0.770
24 0.933 0.930 0.964 24 −0.960 0.127 −0.904
48 0.831 0.600 0.742 48 −0.281 −0.400 0.652
72 0.812 0.726 0.871 72 0.931 0.822 0.877
96 0.791 0.894 −0.066 96 0.869 −0.433 −0.031
CAT BRAIN 12 −0.431 −0.401 0.375 TBARS BRAIN 12 −0.576 −0.033 0.320
24 0.108 0.388 −0.210 24 0.552 0.523 −0.394
48 0.285 −0.477 0.296 48 0.500 0.552 −0.337
72 −0.397 −0.361 −0.450 72 0.010 −0.520 −0.465
96 −0.382 0.397 0.040 96 0.506 −0.462 −0.349
LIVER 12 −0.480 0.270 0.142 LIVER 12 0.562 0.556 −0.003
24 0.146 0.389 0.409 24 −0.012 0.138 −0.447
48 0.300 −0.114 0.239 48 0.199 −0.012 0.575
72 0.374 −0.347 0.412 72 0.576 −0.339 0.159
96 −0.282 0.242 −0.346 96 −0.332 0.567 −0.530
KIDNEY 12 0.395 −0.327 −0.360 KIDNEY 12 0.577 0.574 −0.447
24 0.406 −0.411 0.276 24 −0.351 −0.504 0.520
48 −0.440 −0.442 0.186 48 −0.558 0.408 0.461
72 −0.372 0.348 −0.195 72 0.568 0.562 −0.550
96 −0.435 −0.429 −0.123 96 0.570 −0.190 −0.047
GILL 12 −0.147 −0.465 −0.087 GILL 12 0.566 −0.360 0.553
24 0.303 −0.428 0.413 24 0.311 0.545 0.570
48 0.010 −0.346 0.162 48 −0.315 0.444 0.377
72 0.368 0.405 0.414 72 −0.508 −0.272 0.574
96 −0.343 −0.355 0.278 96 −0.549 −0.174 0.408
BLOOD 12 −0.350 −0.172 0.297 BLOOD 12 0.520 −0.461 −0.139
24 −0.164 −0.325 −0.035 24 −0.398 0.436 −0.410
48 −0.407 −0.425 −0.360 48 −0.061 −0.439 −0.588
72 0.395 −0.336 0.266 72 0.572 0.036 0.172
96 0.390 −0.454 −0.359 96 −0.419 0.940 −0.276
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Antihypertensive medications are metabolized mainly by enzymes
of the P450 family that are present in different body tissues such as
the kidneys, lungs, skin, gut, adrenal cortex, testicles, placenta and
others, but are particularly active in the liver. Different P450 families
have been characterized in fishes such as C. carpio including CYP1,
CYP2, CYP3, CYP4, CYP11, CYP17 and CYP19 (Stegeman and
Livingstone, 1998). Captopril is metabolized by the enzyme CYP2D6.
In the biotransformation of captopril by the CYP2D6 family, ROS are
formed. These ROS can be *OH or oxygenated intermediates, such as the
oxy-cytochrome P450 complex [P450 (Fe3+) O2] resulting from release
of the superoxide anion by reaction decoupling. In both cases, ROS pro-
duction is increased, whichmay explain the LPX andHPC values obtain-
ed in the present study.
Protein damage is induced through oxidation of the side chains of
amino acids; many ROS species can oxidize protein sulfhydryl groups.
In the present study, PCC increases were observed in both liver and
gill at all exposure times, as well as damage induced by all concentra-
tions at 96 h in brain and blood. Blood transports proteins and other
molecules to tissues, while the brain contains a large number of proteins
essential for brain activity and is sensitive to oxidative damage.
These results may be explained by the presence of ROS and reactive
nitrogen species (RNS)\\*OH and ONOO−\\formed in organs such as
the liver, kidneys and gills during captopril biotransformation and in ar-
gininemetabolism, respectively. In particular, ONOO− is highly reactive
and has a high affinity for binding to protein sulfhydryl groups, oxidiz-
ing the protein.
ROS and RNS can remove protons from methylene groups in amino
acids, leading to formation of carbonyls which have a tendency to ligate
protein amines, also damaging nucleophilic centers and inducing sulf-
hydryl group oxidation, disulfide reduction, peptide fragmentation,
modification of prosthetic groups and protein nitration. Thesemodifica-
tions lead to loss of protein function (Cabiscol et al., 2010; Van der Oost
et al., 2003; Glusczak et al., 2007) and therefore also of body integrity
(Parvez and Raisuddin, 2005).
Our results indicate that in most of the organs evaluated and at the
different exposure times, captopril showed no concentration-
dependent effects, since inmost cases the lowest concentration induced
higher increases in antioxidant enzymes. In the case of indicators of cel-
lular oxidation, the two lowest captopril concentrations assayed in-
duced greater change. Although diverse studies (i.e. Cleuvers, 2003,
2005; Nalecz-Jawecki and Sawicki, 2003; Nalecz-Jawecki and Persoone,
2006; Park, 2005; Cunningham et al., 2006; Kaza et al., 2007; NOAA,
2016) state that acute toxicity measured by LC50 in mostly crustaceans
and algae is N100 mg L−1, our study shows that fish species such as
C. carpio are more sensitive to low concentrations of this contaminant.
This makes C. carpio a good candidate for use in evaluating other bio-
markers of exposure to captopril as well as the ecological impact of
this pharmaceutical in aquatic systems.
In our study, captopril concentrations inwater from the test systems
decreased from 12 h on (Table 1) at the two higher concentrations.
These reductions accounted for N70% of the initial concentrations after
96 h. It is worth noting that the HPLC detection limit did not permit de-
termination in test systems where the lowest concentration (1 μg L−1)
was used. Captopril loss in water from the test systems leads us to as-
sume that there was biotransformation of the compound in fish or
else that it underwent photodegradation in the system with possible
presence of metabolites such as captopril disulfide, captopril sulfonic
acid, S-methyl captopril or captopril disulfide S-dioxide (Mahmoud
and Kümmerer, 2012) that were not detected in our study. Further
studies are needed to confirm the formation of captopril metabolites
and degradation products in test systems using C. carpio.
The present study shows that common carp and oxidative stress are
respectively an excellent bioindicator and biomarker for assessment of
the risk associated with captopril presence in aquatic systems even at
very low concentrations.
5. Conclusion
Captopril induced oxidative stress on C. carpio, inducing damage on
lipids mainly in kidney and gill, while protein oxidation occurred in all
organs evaluated except kidney. Antioxidant enzyme activity increased
in all organs, particularly liver, kidney and gill. The biomarkers used
clearly evidence the risk posed by this emerging contaminant to teleost
fishes such as C. carpio.
Table 3 (continued)
Antioxidant activity Oxidative damage
Biomarkers Organs Time (h) Concentration of captopril in water Biomarkers Organs Time (h) Concentration of captopril in water
C-1 C-2 C-3 C-1 C-2 C-3
GPX BRAIN 12 0.211 0.211 0.427 PCC BRAIN 12 0.828 0.935 0.690
24 0.211 0.211 0.427 24 0.876 0.870 0.106
48 0.211 0.211 0.427 48 0.728 0.897 0.961
72 0.211 0.211 0.427 72 0.984 0.120 0.714
96 0.211 0.211 0.427 96 0.827 0.713 0.991
LIVER 12 0.211 0.211 0.427 LIVER 12 0.958 0.777 0.673
24 0.211 0.211 0.427 24 0.881 0.545 0.772
48 0.211 0.211 0.427 48 0.904 0.327 0.944
72 0.211 0.211 0.427 72 0.898 0.560 0.467
96 0.211 0.211 0.427 96 0.929 0.841 0.826
KIDNEY 12 0.211 0.211 0.427 KIDNEY 12 0.784 0.536 0.961
24 0.211 0.211 0.427 24 0.798 0.528 0.734
48 0.211 0.211 0.427 48 0.845 0.997 0.912
72 0.211 0.211 0.427 72 0.943 0.842 0.914
96 0.211 0.211 0.427 96 0.962 0.769 0.972
GILL 12 0.211 0.211 0.427 GILL 12 0.867 0.783 0.709
24 0.211 0.211 0.427 24 0.921 0.929 0.371
48 0.211 0.211 0.427 48 0.832 0.767 0.419
72 0.211 0.211 0.427 72 0.698 0.991 0.841
96 0.211 0.211 0.427 96 0.790 0.827 0.877
BLOOD 12 0.781 0.781 0.570 BLOOD 12 0.983 0.999 0.997
24 0.781 0.781 0.570 24 0.959 0.999 1.000
48 0.781 0.781 0.570 48 0.959 0.973 0.974
72 0.781 0.781 0.570 72 0.896 0.552 0.873
96 0.781 0.781 0.570 96 0.818 0.933 −0.673
Correlation coefficients >0.5 are significant (shown in bold).
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